Symptomatic Hyperprolactinemia
Showing 1 - 25 of 4,637
Hyperprolactinemia Trial in Catonsville (Aripiprazole, Placebo)
Completed
- Hyperprolactinemia
- Aripiprazole
- Placebo
-
Catonsville, MarylandMaryland Psychiatric Research Center
Sep 25, 2019
Hyperprolactinemia and Adrenal Steroidogenesis
Recruiting
- Hyperprolactinemia
-
Bern, SwitzerlandDepartment of Diabetes, Endocrinology, Clinical Nutrition and Me
Nov 14, 2022
Hyperprolactinemia, Prolactinoma Trial in New York (Ropinirole)
Completed
- Hyperprolactinemia
- Prolactinoma
-
New York, New YorkColumbia University Medical Center
Jul 9, 2021
Periodontitis in Schizophrenic Patients
Completed
- Schizophrenia Spectrum and Other Psychotic Disorders
- Periodontal Diseases
- antipsychotic drugs inducing hyperprolactinemia
-
Giza, EgyptRania Hassan Shalby
Sep 10, 2023
Mitral Valve Insufficiency Trial (DragonFly Transcatheter Mitral Valve Repair System)
Not yet recruiting
- Mitral Valve Insufficiency
- DragonFly Transcatheter Mitral Valve Repair System
- (no location specified)
Jun 30, 2023
Quality of Life of the Symptomatic Convergence Insufficiency
Recruiting
- Myopia
- Convergence Insufficiency
- Visual training in hospital
-
Tianjin, ChinaTianjin Eye Hospital
Jul 13, 2023
Revitalization of Traumatized Immature Permanent Teeth
Recruiting
- Apical Periodontitis
- Trauma
- revitalization
-
Ghent, BelgiumGhent University
Sep 12, 2023
Prevalence of Hyperprolactinemia in Systemic Scleroderma
Recruiting
- Sclerosis, Systemic
- +2 more
- blood test
-
Lille, FranceHop Claude Huriez Chu Lille
Oct 4, 2021
Bipolar Disorder Trial in Changsha (No intervention)
Recruiting
- Bipolar Disorder
- No intervention
-
Changsha, ChinaMental Health Institute of 2nd Xiangya Hospital,CSU
Mar 24, 2022
Ureteral Stone Trial in San Francisco (Ureteroscopy)
Not yet recruiting
- Ureteral Stone
- Ureteroscopy
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 2, 2023
Cutaneous Nerves CNS Itch Trial in Minneapolis (Clonidine, Naltrexone)
Completed
- Cutaneous Nerves CNS Itch
-
Minneapolis, MinnesotaUniversity of Minnesota Department of Dermatology
Jan 23, 2023
Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)
Not yet recruiting
- Schizophrenia
- NMDAE
- Placebo Cap
-
Taichung, TaiwanDepartment of Psychiatry, China Medical University Hospital
Sep 4, 2023
Quality of Life Following Rectal Artery Embolization for
Recruiting
- Internal Hemorrhoid
- Rectal Artery Embolization
-
Rochester, MinnesotaMayo Clinic Minnesota
Oct 24, 2023
Chronic Coronary Syndrome, Myocardial Ischemia, Stable Angina Trial in Herning (Optimization of guideline-directed medical
Recruiting
- Chronic Coronary Syndrome
- +3 more
- Optimization of guideline-directed medical therapy
- +3 more
-
Herning, Central Denmark Region, DenmarkGødstrup Hospital
May 23, 2023
Carpal Tunnel Syndrome, CTS Trial in Lexington (Ultrasound Guided Carpal Tunnel Release (CTR-US))
Not yet recruiting
- Carpal Tunnel Syndrome
- CTS
- Ultrasound Guided Carpal Tunnel Release (CTR-US)
-
Lexington, KentuckyBluegrass Orthopaedics
Oct 4, 2023
European Study of Prodromal iNPH
Not yet recruiting
- Normal Pressure Hydrocephalus
- Hydrocephalus
- Shunt surgery
-
Kuopio, Finland
- +6 more
Jun 18, 2023
Cholelithiasis After Bariatric Surgery in Sohag University
Enrolling by invitation
- Cholelithiasis
-
Sohag, EgyptSohag University
Mar 27, 2023
Chronic Inducible Urticaria Trial in Canada, United States (Oral EP262)
Recruiting
- Chronic Inducible Urticaria
- Oral EP262
-
Tampa, Florida
- +5 more
Sep 18, 2023
Mitral Regurgitation Trial (Tioga TMVR System)
Not yet recruiting
- Mitral Regurgitation
- Tioga TMVR System
- (no location specified)
Sep 6, 2023
Desmoid Tumor Trial in France (Cryoablation, Chemotherapy drug)
Not yet recruiting
- Desmoid Tumor
- Cryoablation
- Chemotherapy drug
-
Bordeaux, France
- +12 more
Oct 6, 2023
Neurofibromatosis 1, Plexiform Neurofibroma, NF1 Trial (Test group (Group A): FCN-159 8 mg, orally, once daily;, Control group
Not yet recruiting
- Neurofibromatosis 1
- +2 more
- Test group (Group A): FCN-159 8 mg, orally, once daily;
- Control group (Group B): Placebo, orally, once daily;
- (no location specified)
Jun 16, 2023
Severe Aortic Valve Stenosis Trial in Egypt, Lebanon, Saudi Arabia (Aortic valve replacement)
Not yet recruiting
- Severe Aortic Valve Stenosis
- Aortic valve replacement
-
Aswan, Egypt
- +6 more
May 4, 2023
Asymptomatic Carotid Stenosis, Symptomatic Carotid Stenosis, TCD Trial in New Orleans (Transcranial Doppler (TCD))
Withdrawn
- Asymptomatic Carotid Stenosis
- +3 more
- Transcranial Doppler (TCD)
-
New Orleans, LouisianaOchsner Medical Center
Apr 24, 2023
Stroke, Intracranial Atherosclerotic Stenosis Trial in Beijing (DCB, POBA)
Recruiting
- Stroke
- Intracranial Atherosclerotic Stenosis
- DCB
- POBA
-
Beijing, Beijing, ChinaXuanwu Hospital, Capital Medical University
Sep 19, 2023